Compare Enzyme (MLN) vs Saros (SAROS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Saros — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Saros trades at Rp6.26 (market cap Rp24,09M, Rp10,4M 24h volume). The key difference: Enzyme is far larger — about 5.6× Saros's market cap, and Saros's supply is capped (3,7B / 10B SAROS (38%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Saros for 23 Days on average.
| MLN | SAROS | |
|---|---|---|
Market Cap | Rp134,13M | Rp24,09M |
Volume (24h) | Rp104,56M | Rp10,4M |
Circulating Supply | 3,3M MLN | 3,7B / 10B SAROS (38%) |
Typical Hold Time | 29 Days | 23 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Saros presents as a micro-cap cryptocurrency with a market cap of Rp24.09M and limited circulating supply of 3.7M tokens. The asset shows minimal market activity with low trading volumes and limited exchange presence. Current technical indicators suggest extremely low liquidity and high volatility risk given the small market size.
Overall outlook remains highly speculative with major risks including liquidity constraints and limited adoption. Key opportunity lies in potential ecosystem growth, but investors should be aware of extreme volatility and the project's early-stage development status.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Saros
Saros is a digital identity platform and super app on the Solana blockchain. It started with the SarosSwap decentralized exchange and has grown into a full Web3 ecosystem. Its non-custodial wallet features Social Login, Watch-only mode, and an NFC hybrid wallet for better security and convenience. The wallet integrates with SolanaPay, facilitating efficient transactions through an in-house payment module.
Read more on SAROS →
